IOL Chemicals and Pharmaceuticals Limited

rs,

stries like pharmaceuticals, ink industry, flexible packaging, adhesives, surface coatings, flavours, paints & lamination and essences etc. Captive co-generation unit with capacity of 17 MW to meet pow

17 MW

tings, flavours, paints & lamination and essences etc. Captive co-generation unit with capacity of 17 MW to meet power and steam requirements To be amongst the most admired companies in APIs, Intermedia

30%

ation Iso Butyl Benzene (IBB) commercialised with 8 company worldwide being in India with ~30% Global share products in pipeline backward integrated with ~35% Global share Debt free company

35%

rldwide being in India with ~30% Global share products in pipeline backward integrated with ~35% Global share Debt free company, Spread over a sprawling Zero Discharge Effluent Customer base

rs. 5

umar Rana (Director – Works) after quality assurance, quality control & corporate regulatory affairs. 5 Experienced Independent Directors Rajender Mohan Malla (Chairman and Independent Director) Dr. Sa

13 MW

etformin Unit-5 Clopidogrel & Fenofibrate 2010 2009 2007 Listing on NSE Cogeneration Plant- 13 MW Commencement of IBB, MCA & Acetyl Chloride Unit 07- Metformin Unit 8 & Unit 10 Multi Produc

4 MW

- Metformin Unit 8 & Unit 10 Multi Products Unit 01- Ibuprofen (Dedicated) Cogeneration Plant- 4 MW 2000 Production of Ibuprofen Incorporated Acetic acid 1986- 1991 Commenced Ethyl Acetate Pl

15%

xtiles Ink Paints Pesticides 12 Product wise Segmentation – Quarterly Q2FY22 Q1FY22 Q2FY21 15% 56% 29% 12% 59% 29% Chemicals Ibuprofen 9% 37% 54% Other Pharma Products All figures

56%

s Ink Paints Pesticides 12 Product wise Segmentation – Quarterly Q2FY22 Q1FY22 Q2FY21 15% 56% 29% 12% 59% 29% Chemicals Ibuprofen 9% 37% 54% Other Pharma Products All figures in IN

29%

k Paints Pesticides 12 Product wise Segmentation – Quarterly Q2FY22 Q1FY22 Q2FY21 15% 56% 29% 12% 59% 29% Chemicals Ibuprofen 9% 37% 54% Other Pharma Products All figures in INR crs

12%

ints Pesticides 12 Product wise Segmentation – Quarterly Q2FY22 Q1FY22 Q2FY21 15% 56% 29% 12% 59% 29% Chemicals Ibuprofen 9% 37% 54% Other Pharma Products All figures in INR crs unle

59%

Pesticides 12 Product wise Segmentation – Quarterly Q2FY22 Q1FY22 Q2FY21 15% 56% 29% 12% 59% 29% Chemicals Ibuprofen 9% 37% 54% Other Pharma Products All figures in INR crs unless st

For further details

1